GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹991 Cr | ₹4,348 Cr | ₹3,670 Cr | ₹4,687 Cr | ₹4,869 Cr |
What is the latest Total Debt ratio of GLENMARK PHARMACEUTICALS ?
Year | Total Debt |
---|---|
Mar2024 | ₹991 Cr |
Mar2023 | ₹4,348 Cr |
Mar2022 | ₹3,670 Cr |
Mar2021 | ₹4,687 Cr |
Mar2020 | ₹4,869 Cr |
How is Total Debt of GLENMARK PHARMACEUTICALS Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹991 Cr | -77.22 | |
Mar2023 | ₹4,348 Cr | 18.46 | |
Mar2022 | ₹3,670 Cr | -21.70 | |
Mar2021 | ₹4,687 Cr | -3.72 | |
Mar2020 | ₹4,869 Cr | - |
Compare Total Debt of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹58,227.7 Cr | -0.2% | 13.5% | 42.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹383,570.0 Cr | -1.9% | -4.1% | -6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,808.0 Cr | -3.6% | -12.3% | 27.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,734.0 Cr | -2.1% | 7.2% | 9.3% | Stock Analytics | |
CIPLA | ₹120,468.0 Cr | -0.7% | -0% | -2.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,212.0 Cr | -1.6% | -5.4% | -12.1% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -0.2% |
13.5% |
42.1% |
SENSEX | -0.7% |
-3.7% |
2.4% |
You may also like the below Video Courses